Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)

Clinical trial NCT06385730 · RECRUITING

Trial details

NCT number: NCT06385730
Sponsor: Shanghai Chest Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2024-06-17
Primary completion: 2025-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.